glp-1 drugs competitive intelligence 2025 Long-term Success of GLP-1s Hinges on More Than Just a Prescription GLP-1 Pipeline Update: May 2025

J Diabetes Invest (2013) 4(4):38292

Patients with Hashimoto's typically present with symptoms of hypothyroidism including fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, and cognitive difficulties such as poor concentration or memory problems

Over the past decade, pharmaceutical GLP-1 agonists (initially developed for type 2 diabetes) have demonstrated dramatic weight loss benefits when given at higher doses

Henriksen DB, Alexandersen P, Bjarnason NH, Vilsbll T, Hartmann B, Henriksen EE, et al

According to the International Diabetes Federation, around 537 million adults are living with diabetes

Furthermore, as for cardiac fibroblasts, GLP-1RAs inhibit Ang II and glucose-induced collagen formation via decreasing phospho-NF-B-p65 and phospho-ERK1/2 expression [169] (Figure 2)